Cannell & Spears LLC Decreases Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Cannell & Spears LLC lowered its position in Option Care Health, Inc. (NASDAQ:OPCH) by 1.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,711 shares of the company’s stock after selling 1,189 shares during the quarter. Cannell & Spears LLC’s holdings in Option Care Health were worth $1,408,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Wellington Management Group LLP boosted its position in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock valued at $425,143,000 after buying an additional 8,400,208 shares during the period. FMR LLC lifted its stake in shares of Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Norges Bank purchased a new stake in Option Care Health during the 4th quarter valued at about $60,219,000. Victory Capital Management Inc. grew its position in Option Care Health by 31.1% during the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company’s stock worth $49,310,000 after acquiring an additional 503,840 shares during the last quarter. Finally, Magnetar Financial LLC increased its stake in Option Care Health by 23.1% in the 4th quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company’s stock worth $54,534,000 after purchasing an additional 441,265 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Insider Transactions at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Up 0.6 %

Shares of OPCH stock opened at $34.95 on Tuesday. The company’s fifty day moving average price is $32.58 and its 200-day moving average price is $28.40. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a market capitalization of $5.74 billion, a price-to-earnings ratio of 29.37, a PEG ratio of 2.30 and a beta of 1.33.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. UBS Group began coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. Barrington Research boosted their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities restated a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.